PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin(Y654)

BACKGROUND & AIMS: Identification and validation of new functionally relevant and pharmacologically actionable targets for pancreatic ductal adenocarcinoma (PDAC) remains a great challenge. Premalignant acinar cell reprogramming (acinar-to-ductal metaplasia [ADM]) is a precursor of pancreatic in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Mol Gastroenterol Hepatol
Main Authors: Gao, Chenxi, Chen, Guangming, Zhang, Dennis Han, Zhang, Judy, Kuan, Shih-Fan, Hu, Wenhuo, Esni, Farzad, Gao, Xuan, Guan, Jun-Lin, Chu, Edward, Hu, Jing
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2019
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889497/
https://ncbi.nlm.nih.gov/pubmed/31330317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmgh.2019.07.004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares